Navigation Links
Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
Date:3/25/2013

WESTBURY, N.Y., March 25, 2013 /PRNewswire/ -- Vasomedical, Inc. (OTC BB: VASO), announced today that it will release its financial results for the three months and year ended December 31, 2012 on Monday, April 1, 2013.

The Company will host a conference call on Monday, April 1st at 1:00 p.m. ET featuring remarks by Jun Ma , Ph.D., President and CEO of Vasomedical, and Michael Beecher , Chief Financial Officer of Vasomedical. To dial into the conference call, please dial 1-866-393-1344 from the U.S. or 1-631-291-4669 internationally. All dial-in participants must use the following code to access the call: 26000098. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vasomedical's website, www.vasomedical.com, and www.kcsa.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

A replay of the conference call will be available approximately two hours after completion of the live conference call at www.vasomedical.com or www.kcsa.com. To access the dial-in replay of the call, which will be available until May 1, 2013, please dial 1-855-859-2056 or 1-404-537-3406. All dial-in participants must use the following code to access the call: 26000098.

About Vasomedical
Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products.  The Company's main proprietary products are EECP® Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP® Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments. Additional information is available on the Company's website at www.vasomedical.com.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
212-896-1215 / 212-896-1250
tfromer@kcsa.com / grussell@kcsa.com  


'/>"/>
SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
3. The International EECP Therapists Association and Vasomedical Announce Second Annual EECP Therapy Week
4. Vasomedical Common Stock Commences Trading on the OTCBB
5. Vasomedical Announces Financial Results for the Third Quarter of 2012
6. Vasomedical Named on Deloittes 2012 Technology Fast 500 List
7. Vasomedical Retains KCSA Strategic Communications as Corporate Communications Counsel
8. Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
9. GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
10. Alimera Sciences Reports Fourth Quarter 2012 Financial Results
11. EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... Murrieta ... RESI (Redefining Early Stage Investments) Conference to offer startup companies a special discount ... 10. , The RESI conference series was created by LSN to bring together startups ...
(Date:5/21/2020)... ... 21, 2020 , ... In celebration of Nurses Month, ... set of retail offers and recognized a dedicated group of backers—all collaborating to ... PPE units have arrived to hospitals through commercial, government, and charity efforts, hundreds ...
(Date:5/17/2020)... , ... May 17, 2020 , ... The Sea Cucumber-derived ... and other beneficial properties is extracted from the Sea Cucumber in a proprietary process ... ingredient. , You’ve heard it time and time again: “You get what you ...
Breaking Medicine Technology:
(Date:5/26/2020)... ... May 26, 2020 , ... ... pandemic, medical centers across the United States are joining forces to start a ... who have worked tirelessly to save lives. #FitForTheFrontLine is a national fitness challenge ...
(Date:5/21/2020)... ... May 21, 2020 , ... Fujirebio Diagnostics, Inc., a consolidated ... announced today that Cigna has added ROMA® (Risk of Ovarian Malignancy Algorithm) to ... dedicated to improving the health, well-being, and peace of mind of the customers ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ESO ... and hospitals, today announced the findings of its 2020 ESO Fire Service Index ... of EMS calls versus fire-related calls, first apparatus turnout time and travel time, the ...
(Date:5/17/2020)... Ariz. (PRWEB) , ... May 18, 2020 , ... ... autism stem cell therapy program at its Tijuana regenerative clinic. There are two ... extremely effective and safe cell counts. , While it is unclear exactly what ...
(Date:5/15/2020)... Ill. (PRWEB) , ... May 15, 2020 , ... COVID-19 ... back on their feet by making sure their employees can get back to work ... popular, they have expanded to gyms, restaurants, bars, and countless other settings. , Everyone ...
Breaking Medicine News(10 mins):